BioWorld

July 19, 1994

View Archived Issues

CANGENE SCUTTLES PHARMA PATCH TAKEOVER BID

Read More

GENZYME BUYS SWISS MANUFACTURING FIRM

Read More

BIOMUNE GETS APPROVAL FOR PHASE I TRIAL

Read More

NEUREX COMPLETES AQUISITION OF CREAGEN FOR $85M

Read More

NIH TECHNOLOGY TRANSFER OPPORTUNITIES NEW AIDS VACCINE STRESSES 3-D

Read More

SYNERGEN ANTRIL TRIALS FOR SEPSIS END IN FAILURE

Read More